United Therapeutics (UTHR) Notes Payables (2009 - 2016)

United Therapeutics has disclosed Notes Payables across 8 years of filings, most recently posting $900000.0 for Q2 2016.

• In Q2 2016, Notes Payables fell 97.21% year-over-year to $900000.0; the TTM figure through Jun 2016 stood at $900000.0 (down 97.21% YoY), while the FY2015 annual figure was $5.4 million, down 95.73% from the prior year.
• Notes Payables came in at $900000.0 for Q2 2016 at United Therapeutics, down from $5.4 million in the prior quarter.
• In the past five years, Notes Payables ranged from a high of $224.7 million in Q3 2014 to a low of $900000.0 in Q2 2016.
• Average Notes Payables over 5 years is $115.8 million, with a median of $120.8 million recorded in 2014.
• Year-over-year, Notes Payables surged 16619.21% in 2013 and slumped 97.21% in 2016.
• Over 5 years, Notes Payables stood at $1.3 million in 2012, then surged by 16619.21% to $215.8 million in 2013, then slumped by 41.43% to $126.4 million in 2014, then slumped by 95.73% to $5.4 million in 2015, then slumped by 83.33% to $900000.0 in 2016.
• Per Business Quant data, the three most recent Notes Payables figures were $900000.0 in Q2 2016, $5.4 million in Q1 2016, and $5.4 million in Q4 2015.